A Phase II study to evaluate the safety and potential palliative benefit of intraperitoneal bevacizumab in patients with symptomatic ascites due to advanced chemotherapy resistant gynaecological cancers: REZOLVE dataset
收藏DataCite Commons2024-07-16 更新2025-04-17 收录
下载链接：
https://ses.library.usyd.edu.au/handle/2123/32798
下载链接
链接失效反馈官方服务：
资源简介：
HeSANDA 1.0.0
提供机构：
University of Sydney
创建时间：
2024-07-16
